J. Zaltzman

发表

Mycophenolate Mofetil and C-Reactive Protein in Renal Transplant Recipients

G. Prasad, Brian M. Wong, Michael Huang, 2007, Transplantation.

Kidney transplantation in the elderly: a decision analysis.

G. Naglie, D. Redelmeier, M. Krahn, 2003, Journal of the American Society of Nephrology : JASN.

Management of the neurologically deceased organ donor: A Canadian clinical practice guideline

M. Meade, S. Keenan, L. Hornby, 2020, Canadian Medical Association Journal.

Study of Cardiovascular Outcomes in Renal Transplantation: A Prospective, Multicenter Study to Determine the Incidence of Cardiovascular Events in Renal Transplant Recipients in Ontario, Canada

D. Holland, G. Knoll, S. Kim, 2017, Canadian journal of kidney health and disease.

Long‐term clinical outcomes of nocturnal hemodialysis patients compared with conventional hemodialysis patients post‐renal transplantation

Christopher T. Chan, J. Hanley, A. Pierratos, 2009, Clinical transplantation.

Organ donation after cardiac death: donor and recipient outcomes after the first three years of the Ontario experience

S. Keshavjee, G. Knoll, A. Jevnikar, 2011, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes.

A. Yan, M. Tan, D. Fitchett, 2006, The Canadian journal of cardiology.

Commercial kidney transplantation is an important risk factor in long-term kidney allograft survival.

G. Prasad, Michael Huang, J. Zaltzman, 2016, Kidney international.

The benefits of renin-angiotensin blockade in renal transplant recipients with biopsy-proven allograft nephropathy.

J. Zaltzman, M. Nash, R. Prasad, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Five-Year Study of Tacrolimus as Secondary Intervention Versus Continuation of Cyclosporine in Renal Transplant Patients at Risk for Chronic Renal Allograft Failure

D. Rush, B. Kiberd, S. Paraskevas, 2008, Transplantation.

Safety and efficacy of recombinant human erythropoietin in correcting the anemia of patients with chronic renal allograft dysfunction.

D. Cattran, P. Keown, K. Jindal, 1994, Journal of the American Society of Nephrology : JASN.

Accurate measurement of impaired glomerular filtration using single-dose oral cimetidine.

A. Logan, D. Cattran, J. Zaltzman, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

COVID-19 Outbreak in an Urban Hemodialysis Unit

J. Weinstein, L. Matukas, W. Beaubien-Souligny, 2020, American Journal of Kidney Diseases.

Blood pressure reduction with HMG-CoA reductase inhibitors in renal transplant recipients.

G. Prasad, J. Zaltzman, M. Nash, 2003, Kidney international.

The role of thrombectomy and diffusion-weighted imaging with MRI in post-transplant renal vein thrombosis: a case report

J. Lee, A. Kirpalani, G. Leung, 2017, BMC Nephrology.

The role of dietary cations in the blood pressure of renal transplant recipients

G. R. Ramesh Prasad, Michael Huang, J. Zaltzman, 2006, Clinical transplantation.

Handwashing precautions taken by renal transplant recipients for severe acute respiratory syndrome.

G. Prasad, J. Zaltzman, M. Nash, 2004, Transplantation.

Seasonal variation in outpatient blood pressure in stable renal transplant recipients.

G. Prasad, J. Zaltzman, M. Nash, 2001, Transplantation.

Seasonal Variation of Serum Lipid Levels in Stable Renal Transplant Recipients

G. Prasad, Brian M. Wong, Michael Huang, 2007, Nephron Clinical Practice.

Clinical practice guidelines: prevention of cytomegalovirus disease after renal transplantation.

M Krajden, C. Cardella, D. Cattran, 1998, Journal of the American Society of Nephrology : JASN.

Review of clinical outcomes in nocturnal haemodialysis patients after renal transplantation.

Christopher T. Chan, S. Fenton, A. Pierratos, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Outcome of kidney transplantation from high-risk donors is determined by both structure and function.

J Karpinski, C. Cardella, D. Cattran, 1999, Transplantation.

A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteers

D. Cherney, J. Zaltzman, V. Lai, 2014, Transplant international : official journal of the European Society for Organ Transplantation.

Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneys

G. Prasad, Michael Huang, J. Zaltzman, 2022, BMC Nephrology.

Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.

A. Matas, J. Pirsch, Joshua Miller, 2007, Transplantation.

Quinolone prophylaxis for the prevention of BK virus infection in kidney transplantation: study protocol for a randomized controlled trial

A. Humar, G. Knoll, A. House, 2013, Trials.

Canadian Forum on Combined Organ Transplantation

P. Nickerson, A. Dipchand, S. Kim, 2016, Transplantation.

Effect of organ donation after circulatory determination of death on number of organ transplants from donors with neurologic determination of death

A. Humar, S. Dhanani, J. Zaltzman, 2017, Canadian Medical Association Journal.

Safety and Efficacy of Recombinant Human Eryfhropoietin in Correcting the Anemia of Patients With Chronic Renal Allograft Dysfunction1

Wong, First, A., 2005 .

Role of dietary salt intake in posttransplant hypertension with tacrolimus-based immunosuppression.

G. Prasad, J. Zaltzman, M. Nash, 2005, Transplantation proceedings.

CYCLOSPORINE NEPHROTOXICITY IN LUNG TRANSPLANT RECIPIENTS

D. Cattran, J. Maurer, J. Zaltzman, 1992, Transplantation.

Lithium-Induced Minimal Change Disease and Acute Kidney Injury

J. Zaltzman, P. Tandon, N. Wong, 2015, North American journal of medical sciences.

Mycophenolate mofetil causing deep venous thrombosis in a renal transplant patient with factor V Leiden.

J. Zaltzman, D. Cherney, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A Numerical Scale Comparison of Renal Transplant Recipient Experience with and Opinions about Calcineurin Inhibitors

P. McFarlane, G. Prasad, J. Zaltzman, 2004, Nephron Clinical Practice.

Renal transplant recipient attitudes toward steroid use and steroid withdrawal

P. McFarlane, G. Prasad, J. Zaltzman, 2003, Clinical transplantation.

A Clinical and Pathological Variant of Acute Transplant Glomerulopathy

M. Molnar, G. Prasad, S. Jothy, 2014, Case reports in pathology.

Reduction in new-onset diabetes mellitus after renal transplant with erythropoietin-stimulating agents: a retrospective cohort study

M. Woo, R. Retnakaran, G. Prasad, 2016, Canadian journal of kidney health and disease.

Prophylactic antilymphocyte antibody therapy in kidney transplantation: Quo vadis?

L. Paul, J. Zaltzman, Carl J.Cardella, 1995 .

A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group.

D. Rush, P. Parfrey, R. Loertscher, 1996, Transplantation.

Organ donation after cardiac death: donor and recipient outcomes after the first three years of the Ontario experience Le don d'organes apresu n deces cardiaque: les devenirs des donneurs et des recipiendaires apres les trois premieres annees de l'experience ontarienne

G. Prasad, P. Luke, J. Zaltzman, 2011 .

Thrombotic microangiopathy in renal transplant recipients treated with cyclosporin A.

C. Cardella, D. Cattran, S. Quaggin, 1997, Clinical nephrology.

A prospective 3‐yr evaluation of tacrolimus‐based immunosuppressive therapy in immunological high risk renal allograft recipients

S. Busque, D. Landsberg, Vivian Charles McAlister, 2005, Clinical transplantation.

factor in long-term kidney allograft survival Commercial kidney transplantation is an important risk

G. Prasad, Michael Huang, J. Zaltzman, 2016 .

Kidney transplant tourism: cases from Canada

J. Gill, J. Zaltzman, L. Wright, 2013, Medicine, health care, and philosophy.

Outcomes of Commercial Renal Transplantation: A Canadian Experience

G. Prasad, Ashutosh M. Shukla, G. Prasad, 2006, Transplantation.

A prospective study of the physician effect on blood pressure in renal-transplant recipients.

G. Prasad, J. Zaltzman, M. Nash, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A Comparison of Short-Term Exposure of Once-Daily Extended Release Tacrolimus and Twice-Daily Cyclosporine on Renal Function in Healthy Volunteers

J. Zaltzman, 2010, Transplantation.

Enhance Access to Kidney Transplantation and Living Kidney Donation (EnAKT LKD): Statistical Analysis Plan of a Registry-Based, Cluster-Randomized Clinical Trial

A. Garg, A. Waterman, S. Dixon, 2022, Canadian journal of kidney health and disease.

ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.

M. Vivera, J. Zaltzman, J. Cohen, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial

L. Cámpora, Deepali Kumar, A. Secchi, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation

G. Prasad, Michael Huang, J. Zaltzman, 2019, BMC Infectious Diseases.

Severe and near-fatal anaphylactic reactions triggered by chlorhexidine-coated catheters in patients undergoing renal allograft surgery: a case series

S. Tarlo, P. Vadas, G. Hare, 2019, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

Severe anaphylactic reactions caused by chlorhexidine-coated central venous lines during renal transplantation

P. Vadas, J. Zaltzman, L. Fu, 2017 .

In reply: Assessing the need for a chlorhexidine-containing central venous catheter: balancing the risk of anaphylaxis with infection

P. Vadas, J. Zaltzman, A. Ho, 2020, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

A Quality Improvement Intervention to Enhance Access to Kidney Transplantation and Living Kidney Donation (EnAKT LKD) in Patients With Chronic Kidney Disease: Clinical Research Protocol of a Cluster-Randomized Clinical Trial

A. Garg, A. Waterman, S. Dixon, 2021, Canadian journal of kidney health and disease.

Adenovirus-induced hemorrhagic cystitis in association with cytomegalovirus infection in renal allograft recipients.

J. Zaltzman, R. Honey, N. Struthers, 1994, Transplantation.

Community-acquired West Nile virus infection in solid-organ transplant recipients

Deepali Kumar, A. Humar, G. Prasad, 2004, Transplantation.

Retrospective Analysis of Tacrolimus Intrapatient Variability as a Measure of Medication Adherence

G. Prasad, Michael Huang, J. Zaltzman, 2021, Canadian journal of kidney health and disease.

Ritonavir-boosted antiretroviral therapy precipitating tacrolimus toxicity in a renal transplant patient: is it time for a priori tacrolimus dosage reduction?

I. Fong, J. Zaltzman, Mark Naccarato, 2021, AIDS.

A Comparison of the Effects of C2-Cyclosporine and C0-Tacrolimus on Renal Function and Cardiovascular Risk Factors in Kidney Transplant Recipients

C. Cardella, D. Cattran, S. Kim, 2006, Transplantation.

IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer.

M. Overholtzer, E. Amir, J. Zaltzman, 2015, Biochemical and biophysical research communications.

Post-renal transplantation hyponatremia.

J. Zaltzman, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

RENAL TRANSPLANTATION WITHOUT STEROIDS ‐ ONE YEAR RESULTS OF A MULTICENTRE CANADIAN PILOT STUDY.: Abstract# 86

B. Kiberd, P. Halloran, E. Cole, 2000 .

A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients.

B. Kiberd, P. Halloran, D. Landsberg, 2001, Transplantation.

Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial.

X. Pang, A. Humar, G. Knoll, 2014, JAMA.

The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipients

G. Prasad, Michael Huang, J. Zaltzman, 2016, Transplantation research.

A comparison of the extended-release and standard-release formulations of tacrolimus in de novo kidney transplant recipients: a 12-month outcome study

G. Prasad, C. Campbell, Michael Huang, 2012, Clinical kidney journal.

A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity

J. Zaltzman, A. Sokwala, M. Nash, 2014, Transplantation research.

Canadian Society of Allergy and Clinical Immunology annual scientific meeting 2016

Young Woong Kim, H. Pasterkamp, T. Schuster, 2017, Allergy, Asthma & Clinical Immunology.

Role of Magnetic Resonance Elastography as a Noninvasive Measurement Tool of Fibrosis in a Renal Allograft: A Case Report.

A. Kirpalani, G. Mnatzakanian, G. Leung, 2017, Transplantation proceedings.

Development of focal segmental glomerulosclerosis in the renal allograft of a patient with lupus.

L. Sugar, J. Zaltzman, J. S. Kim, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients.

J. Zaltzman, M. Nash, 1998, Transplantation.

Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient: a new treatment strategy.

F. Jeejeebhoy, J. Zaltzman, 1998, Transplantation.

A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients

C. Cardella, D. Cattran, J. Gill, 2013, Transplantation research.

Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.

G. Prasad, Michael Huang, J. Zaltzman, 2009, The American journal of cardiology.

Death with graft function in elderly patients after cadaveric renal transplantation: effect of waiting time.

P. Noseworthy, G. R. Ramesh Prasad, J. Zaltzman, 2004, Transplantation proceedings.

South Asian ethnicity as a risk factor for major adverse cardiovascular events after renal transplantation.

S. Silver, G. Prasad, Michael Huang, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Microalbuminuria post‐renal transplantation: relation to cardiovascular risk factors and C‐reactive protein

G. R. Ramesh Prasad, Michael Huang, J. Zaltzman, 2009, Clinical transplantation.

The First North American Experience Using Glycosorb Immunoadsorption Columns for Blood Group–Incompatible Kidney Transplantation

K. Pavenski, J. Zaltzman, G. Prasad, 2020, Canadian journal of kidney health and disease.

Public solicitation for organ donors: a time for direction in Canada

J. Zaltzman, L. Wright, Aviva Elman, 2016, Canadian Medical Association Journal.

Diltiazem use in tacrolimus‐treated renal transplant recipients

G. R. Ramesh Prasad, J. Zaltzman, M. Nash, 2004, Journal of clinical pharmacy and therapeutics.

DAMPAned Methotrexate: A Case Report and Review of the Management of Acute Methotrexate Toxicity

J. Perl, D. Beriault, J. Zaltzman, 2019, Canadian journal of kidney health and disease.

Organ Donation after Medical Assistance in Dying - Canada's First Cases.

S. Keenan, F. Priestap, I. Ball, 2020, The New England journal of medicine.

Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study Group.

R. Loertscher, D. Landsberg, P. Keown, 1998, Transplantation.

SAFETY AND TOLERABILITY OF CYCLOSPORINE AND CYCLOSPORINE MICROEMULSION DURING 18 MONTHS OF FOLLOW-UP IN STABLE RENAL TRANSPLANT RECIPIENTS

Lisa Anne Hendricks, Nova Scotia, R. Loertscher, 1998 .

The use of angiotensin-converting enzyme inhibitors in renal transplant patients

L. Paul, J. Zaltzman, 1998 .

Development of Encapsulating Peritoneal Sclerosis in a Renal Transplant Recipient on Sirolimus Immunotherapy

J. Perl, J. Zaltzman, S. Temple, 2010, Peritoneal Dialysis International.

Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantation.

G. R. Ramesh Prasad, J. Zaltzman, L. Rapi, 2009, Clinical Nephrology.

Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis

J. A. Miller, D. Naimark, Z. Harel, 2022, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Renal transplantation in older patients: the University of Toronto experience

V. Farewell, Y. Pei, C. Cardella, 1995 .

Metabolic syndrome definitions and components in predicting major adverse cardiovascular events after kidney transplantation

S. Silver, G. Prasad, Michael Huang, 2015, Transplant international : official journal of the European Society for Organ Transplantation.

Impact of kidney transplantation on sleep apnoea in patients with end-stage renal disease.

P. Hanly, J. Zaltzman, R. Prasad, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Reduced Incidence of New‐Onset Diabetes Mellitus after Renal Transplantation with 3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Inhibitors (Statins)

C. Cardella, D. Cattran, G. Prasad, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients.

S. Busque, D. Landsberg, J. Tchervenkov, 2001, Transplantation proceedings.

Is There a Role for mTOR Inhibitors in Renal Transplantation?

J. Zaltzman, 2017, Transplantation.

Resolution of renal allograft-associated post-transplant lymphoproliferative disorder with the introduction of sirolimus.

S. Jothy, K. Chun, J. Zaltzman, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

VIGNETTE IN CLINICAL PATHOPHYSIOLOGY Post-Renal Transplantation Hyponatremia

J. Zaltzman, 1996 .

ReplyNDT Plus (2010)

Alok Gupta, S. Jothy, J. Zaltzman, 2010 .

Alok Gupta, S. Jothy, J. Zaltzman, 2010, NDT plus.

Alok Gupta, S. Jothy, J. Zaltzman, 2010 .

alpha-smooth muscle actin and collagen deposition in dysfunctional renal transplants.

L. Sugar, L. Paul, J. Zaltzman, 1997, Transplantation.

Statin Use and Bone Mineral Density in Renal Transplant Recipients

G. Prasad, J. Zaltzman, M. Nash, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Kidney transplantation in the elderly: a decision analysis.

S. Jassal, J. Zaltzman, Edward H. Cole, 2003, Journal of the American Society of Nephrology : JASN.

Continuous Ambulatory Peritoneal Dialysis and Nutritional Adequacy

S. Fenton, J. Zaltzman, Jeffrey S. Zaltzman, 1992 .

Kidney transplantation in the elderly: a decision analysis.

S. Jassal, J. Zaltzman, Edward H. Cole, 2003, Journal of the American Society of Nephrology : JASN.

Sustained vasoconstriction associated with daily cyclosporine dose in heart and lung transplant recipients: potential pathophysiologic role of endothelin.

C. Cardella, D. Cattran, J. Zaltzman, 1995, The Journal of laboratory and clinical medicine.

Hypocomplementaemic immune complex tubulointerstitial nephritis

Alok Gupta, S. Jothy, J. Zaltzman, 2009, NDT plus.

Safety and Efficacy of Recombinant Human Eryfhropoietin in Correcting the Anemia of Patients With Chronic Renal Allograft Dysfunction1

Wong, First, A., 2005 .